Get the Stockscreener App
273.26
0.53%
-1.46
After Hours:
273.26
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $273.26, with a volume of 454.20K.
It is down -0.53% in the last 24 hours and down -0.13% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$274.72
Open:
$272.4
24h Volume:
454.20K
Relative Volume:
0.66
Market Cap:
$22.52B
Revenue:
$13.95B
Net Income/Loss:
$877.70M
P/E Ratio:
26.13
EPS:
10.4589
Net Cash Flow:
$1.21B
1W Performance:
-0.17%
1M Performance:
-0.13%
6M Performance:
-1.63%
1Y Performance:
+18.56%
1-Day Range:
$270.98
$276.37
1-Week Range:
$268.75
$277.92
52-Week Range:
$209.38
$293.72
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
273.26 | 22.64B | 13.95B | 877.70M | 1.21B | 10.46 |
TMO
Thermo Fisher Scientific Inc
|
500.46 | 187.10B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
192.99 | 138.84B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
584.75 | 47.01B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.39 | 33.04B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
317.65 | 31.25B | 3.17B | 642.63M | 516.49M | 10.77 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Labcorp declares $0.72 quarterly dividend per share By Investing.com - Investing.com Australia
Labcorp Holdings Inc. (NYSE:LH) Plans Quarterly Dividend of $0.72 - MarketBeat
Labcorp Holdings Inc. Declares Quarterly Dividend, Payable on June 11, 2026 - marketscreener.com
Willis Investment Counsel Boosts Stock Holdings in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Declares $0.72 Quarterly Dividend Payable June 11, 2026 - Minichart
Labcorp Holdings Inc. (LH) Announces Cash Dividend for Shareholders - GuruFocus
Labcorp Declares Quarterly Cash Dividend, Signals Ongoing Confidence - TipRanks
Labcorp Holdings Keeps Quarterly Dividend at $0.72 a Share, Payable June 11 to Shareholders of Record as of May 29 - marketscreener.com
Labcorp Declares Quarterly Dividend - GuruFocus
Labcorp (NYSE: LH) sets $0.72 quarterly dividend payable June 11 - Stock Titan
Press Release: Labcorp Declares Quarterly Dividend - 富途牛牛
Oak Thistle LLC Invests $1.72 Million in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc. (NYSE:LH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Labcorp Holdings Inc. stock rises Wednesday, still underperforms market - MarketWatch
Evercore ISI Group Raises Labcorp Holdings (LH) Price Target to $300 | LH Stock News - GuruFocus
Raleigh Capital Management Inc. Sells 11,248 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Boca Firm Sues Labcorp Over Unpaid Asset Recovery Work - National Today
Labcorp Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Should You Keep LH Stock in Your Investment Portfolio? - Bitget
Should You Continue to Hold LH Stock in Your Portfolio? - TradingView
Labcorp falls as 2025 revenue guidance midpoint lowered - MSN
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock - Yahoo Finance
LH PE Ratio & Valuation, Is LH Overvalued - Intellectia AI
Nearly 300 N.J. healthcare layoffs: Novartis, Labcorp among companies cutting jobs - Yahoo Finance
Labcorp (NYSE:LH) Lowered to Hold Rating by Wall Street Zen - marketbeat.com
Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor Intelligence - GlobeNewswire Inc.
LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest - Yahoo
Labcorp Holdings Inc. (0JSY.L) stock price, news, quote and history - Yahoo Finance UK
HSBC Adjusts Price Target on Labcorp Holdings to $270 From $260, Maintains Hold Rating - marketscreener.com
Labcorp Holdings Inc. (LH) Stock forecasts - uk.finance.yahoo.com
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp to offer Roche, Lilly Alzheimer's blood test starting in early 2026 - MSN
Assenagon Asset Management S.A. Sells 32,625 Shares of Labcorp Holdings Inc. $LH - MarketBeat
8 KNOTS MANAGEMENT, LLC's Labcorp Holdings Inc(LH) Holding History - GuruFocus
Labcorp Holdings Inc. (LH) Stock Forecasts - Yahoo! Finance Canada
Labcorp Sets Date for First-Quarter 2026 Results - TipRanks
Labcorp to Announce First Quarter Financial Results on April 30, 2026 - Lelezard
Labcorp Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
Labcorp (NYSE: LH) schedules Q1 2026 earnings release and webcast - Stock Titan
Allspring Global Investments Holdings LLC Boosts Stake in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp will post first-quarter results before markets open April 30 - Stock Titan
Sentiment Review: Can Labcorp Holdings Inc disrupt its industryDollar Strength & Daily Stock Trend Reports - baoquankhu1.vn
Labcorp EVP Meltzer sells $224k in shares By Investing.com - Investing.com Canada
Labcorp SVP Wilkinson sells $436k in shares - Investing.com
Labcorp SVP Wilkinson sells $436k in shares By Investing.com - Investing.com India
Labcorp (NYSE: LH) CEO receives 58,470-share award, 26,106 withheld for taxes - Stock Titan
Labcorp (LH) EVP granted 6,604 shares; 2,879 withheld for tax - stocktitan.net
Labcorp (NYSE: LH) EVP granted performance stock; shares withheld for tax - Stock Titan
Labcorp (LH) EVP gets performance shares; 4,905 shares withheld for taxes - stocktitan.net
Labcorp (NYSE: LH) SVP sells shares after award under Rule 10b5-1 - Stock Titan
Labcorp (LH) EVP gets 1,584-share award, 451 withheld for taxes - stocktitan.net
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):